Richard Kenley, Ph.D.
Executive Vice President and General Manager
Biotechnology Facility

Richard A. Kenley is a graduate of the University of Illinois with a B.Sc. in Chemistry and a graduate of the University of California, San Diego with a Ph.D. degree in Organic Chemistry. Currently he is Managing Director of the Magellan Laboratories Biotechnology Facility. From 1994 through 1999, he was Sr. Vice President of Product Development within Amylin Pharmaceuticals, Inc., reporting to the President.

Previously, as Director of Pharmaceutical Development at Genetics Institute he was responsible for finished product development of various new recombinant therapeutics, to include: rhIL-11, rhBMP-2, rhM-CSF, and bFGF. At Genetics Institute Dr. Kenley supervised dosage form development, analytical method development, clinical trial manufacturing, and stability testing activities. He also directed the research and development of novel drug delivery techniques for rhBMP-2.

Before joining Genetics Institute, Dr. Kenley was Associate Director of Chemistry R&D at Baxter Healthcare Parenterals Division, in Round Lake, IL. At Baxter, Dr. Kenley was responsible for analytical chemistry of new product R&D, regulatory issues, and product/manufacturing support. The business area of emphasis was parenteral products to include premixed drug solutions for IV administration, and new polymers for container manufacture. Analytical techniques included chromatography, atomic spectroscopy, mass spec, and NMR.

Prior to his assignment at Baxter, Dr. Kenley was Department Head in Pharmaceutical Analysis at Syntex Research. There he was responsible for developing analytical methods to ascertain potency and stability of formulated drug products. Drug categories of interest included: corticosteroids, NSAID's, prostaglandins, peptide LHRH antagonists, non-narcotic analgesics, antimycotics, antihypertensive Ca channel blockers, antiviral nucleoside analogs, and anti-psoriatics. Dosage forms included controlled-release bioabsorbable injectables.

Dr. Kenley has over 50 research publications and is a member of American Chemical Society and American Association of Pharmaceutical Scientists.